PROGYNY INC (PGNY) Fundamental Analysis & Valuation

NASDAQ:PGNY • US74340E1038

Current stock price

18.6 USD
+0.02 (+0.11%)
At close:
18.6 USD
0 (0%)
After Hours:

This PGNY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. PGNY Profitability Analysis

1.1 Basic Checks

  • PGNY had positive earnings in the past year.
  • In the past year PGNY had a positive cash flow from operations.
  • PGNY had positive earnings in each of the past 5 years.
  • Each year in the past 5 years PGNY had a positive operating cash flow.
PGNY Yearly Net Income VS EBIT VS OCF VS FCFPGNY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.88%, PGNY belongs to the top of the industry, outperforming 90.10% of the companies in the same industry.
  • PGNY's Return On Equity of 11.34% is fine compared to the rest of the industry. PGNY outperforms 75.25% of its industry peers.
  • With an excellent Return On Invested Capital value of 10.67%, PGNY belongs to the best of the industry, outperforming 83.17% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for PGNY is in line with the industry average of 8.40%.
  • The 3 year average ROIC (9.10%) for PGNY is below the current ROIC(10.67%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.88%
ROE 11.34%
ROIC 10.67%
ROA(3y)8.34%
ROA(5y)9.8%
ROE(3y)11.81%
ROE(5y)13.92%
ROIC(3y)9.1%
ROIC(5y)7.81%
PGNY Yearly ROA, ROE, ROICPGNY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • PGNY has a better Profit Margin (4.54%) than 75.25% of its industry peers.
  • In the last couple of years the Profit Margin of PGNY has declined.
  • PGNY's Operating Margin of 7.06% is fine compared to the rest of the industry. PGNY outperforms 72.28% of its industry peers.
  • In the last couple of years the Operating Margin of PGNY has grown nicely.
  • The Gross Margin of PGNY (23.63%) is comparable to the rest of the industry.
  • PGNY's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.06%
PM (TTM) 4.54%
GM 23.63%
OM growth 3Y33.54%
OM growth 5Y21.46%
PM growth 3Y5.54%
PM growth 5Y-19.56%
GM growth 3Y3.58%
GM growth 5Y3.06%
PGNY Yearly Profit, Operating, Gross MarginsPGNY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

10

2. PGNY Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PGNY is creating some value.
  • PGNY has less shares outstanding than it did 1 year ago.
  • PGNY has less shares outstanding than it did 5 years ago.
  • PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PGNY Yearly Shares OutstandingPGNY Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
PGNY Yearly Total Debt VS Total AssetsPGNY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • PGNY has an Altman-Z score of 6.95. This indicates that PGNY is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 6.95, PGNY belongs to the best of the industry, outperforming 94.06% of the companies in the same industry.
  • PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.95
ROIC/WACC1.18
WACC9.03%
PGNY Yearly LT Debt VS Equity VS FCFPGNY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 2.73 indicates that PGNY has no problem at all paying its short term obligations.
  • PGNY's Current ratio of 2.73 is amongst the best of the industry. PGNY outperforms 83.17% of its industry peers.
  • PGNY has a Quick Ratio of 2.73. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.73, PGNY belongs to the top of the industry, outperforming 83.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.73
PGNY Yearly Current Assets VS Current LiabilitesPGNY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. PGNY Growth Analysis

3.1 Past

  • PGNY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.04%, which is quite good.
  • PGNY shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 52.04% yearly.
  • The Revenue has grown by 10.40% in the past year. This is quite good.
  • Measured over the past years, PGNY shows a very strong growth in Revenue. The Revenue has been growing by 30.16% on average per year.
EPS 1Y (TTM)14.04%
EPS 3Y29.4%
EPS 5Y52.04%
EPS Q2Q%16.67%
Revenue 1Y (TTM)10.4%
Revenue growth 3Y17.87%
Revenue growth 5Y30.16%
Sales Q2Q%6.69%

3.2 Future

  • PGNY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.30% yearly.
  • Based on estimates for the next years, PGNY will show a small growth in Revenue. The Revenue will grow by 5.69% on average per year.
EPS Next Y106.98%
EPS Next 2Y53.37%
EPS Next 3Y39.68%
EPS Next 5Y27.3%
Revenue Next Year7.67%
Revenue Next 2Y8.71%
Revenue Next 3Y8.23%
Revenue Next 5Y5.69%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PGNY Yearly Revenue VS EstimatesPGNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
PGNY Yearly EPS VS EstimatesPGNY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. PGNY Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 28.62, PGNY can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as PGNY.
  • When comparing the Price/Earnings ratio of PGNY to the average of the S&P500 Index (26.64), we can say PGNY is valued inline with the index average.
  • PGNY is valuated correctly with a Price/Forward Earnings ratio of 13.83.
  • PGNY's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PGNY is cheaper than 77.23% of the companies in the same industry.
  • PGNY is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.36, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.62
Fwd PE 13.83
PGNY Price Earnings VS Forward Price EarningsPGNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • PGNY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PGNY is cheaper than 74.26% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PGNY indicates a rather cheap valuation: PGNY is cheaper than 90.10% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.6
EV/EBITDA 9.89
PGNY Per share dataPGNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • PGNY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • PGNY has a very decent profitability rating, which may justify a higher PE ratio.
  • PGNY's earnings are expected to grow with 39.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.27
PEG (5Y)0.55
EPS Next 2Y53.37%
EPS Next 3Y39.68%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PGNY Dividend Analysis

5.1 Amount

  • PGNY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PGNY Fundamentals: All Metrics, Ratios and Statistics

PROGYNY INC

NASDAQ:PGNY (5/1/2026, 8:00:01 PM)

After market: 18.6 0 (0%)

18.6

+0.02 (+0.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength39.75
Industry Growth70.81
Earnings (Last)02-26
Earnings (Next)05-07
Inst Owners107.66%
Inst Owner Change1.43%
Ins Owners1.81%
Ins Owner Change3.2%
Market Cap1.46B
Revenue(TTM)1.29B
Net Income(TTM)58.52M
Analysts83.53
Price Target28.1 (51.08%)
Short Float %7.2%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.44%
Min EPS beat(2)-5.34%
Max EPS beat(2)14.22%
EPS beat(4)2
Avg EPS beat(4)2.94%
Min EPS beat(4)-11.77%
Max EPS beat(4)14.63%
EPS beat(8)4
Avg EPS beat(8)4.01%
EPS beat(12)8
Avg EPS beat(12)21.97%
EPS beat(16)12
Avg EPS beat(16)74.68%
Revenue beat(2)2
Avg Revenue beat(2)2.09%
Min Revenue beat(2)1.53%
Max Revenue beat(2)2.66%
Revenue beat(4)4
Avg Revenue beat(4)2.33%
Min Revenue beat(4)1.53%
Max Revenue beat(4)3.19%
Revenue beat(8)5
Avg Revenue beat(8)0.19%
Revenue beat(12)8
Avg Revenue beat(12)0.58%
Revenue beat(16)10
Avg Revenue beat(16)0.45%
PT rev (1m)0%
PT rev (3m)-8.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)32.84%
EPS NY rev (1m)27.69%
EPS NY rev (3m)41.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.68%
Valuation
Industry RankSector Rank
PE 28.62
Fwd PE 13.83
P/S 1.13
P/FCF 7.6
P/OCF 6.93
P/B 2.82
P/tB 2.97
EV/EBITDA 9.89
EPS(TTM)0.65
EY3.49%
EPS(NY)1.35
Fwd EY7.23%
FCF(TTM)2.45
FCFY13.16%
OCF(TTM)2.68
OCFY14.43%
SpS16.45
BVpS6.59
TBVpS6.25
PEG (NY)0.27
PEG (5Y)0.55
Graham Number9.81583 (-47.23%)
Profitability
Industry RankSector Rank
ROA 7.88%
ROE 11.34%
ROCE 16.85%
ROIC 10.67%
ROICexc 25.05%
ROICexgc 28.27%
OM 7.06%
PM (TTM) 4.54%
GM 23.63%
FCFM 14.88%
ROA(3y)8.34%
ROA(5y)9.8%
ROE(3y)11.81%
ROE(5y)13.92%
ROIC(3y)9.1%
ROIC(5y)7.81%
ROICexc(3y)21.68%
ROICexc(5y)17.45%
ROICexgc(3y)23.75%
ROICexgc(5y)19.08%
ROCE(3y)14.37%
ROCE(5y)12.33%
ROICexgc growth 3Y51.65%
ROICexgc growth 5Y21.09%
ROICexc growth 3Y48.79%
ROICexc growth 5Y23.47%
OM growth 3Y33.54%
OM growth 5Y21.46%
PM growth 3Y5.54%
PM growth 5Y-19.56%
GM growth 3Y3.58%
GM growth 5Y3.06%
F-Score6
Asset Turnover1.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 372.07%
Cap/Sales 1.43%
Interest Coverage 250
Cash Conversion 219.12%
Profit Quality 327.72%
Current Ratio 2.73
Quick Ratio 2.73
Altman-Z 6.95
F-Score6
WACC9.03%
ROIC/WACC1.18
Cap/Depr(3y)234.02%
Cap/Depr(5y)213.68%
Cap/Sales(3y)0.74%
Cap/Sales(5y)0.61%
Profit Quality(3y)315.29%
Profit Quality(5y)247.21%
High Growth Momentum
Growth
EPS 1Y (TTM)14.04%
EPS 3Y29.4%
EPS 5Y52.04%
EPS Q2Q%16.67%
EPS Next Y106.98%
EPS Next 2Y53.37%
EPS Next 3Y39.68%
EPS Next 5Y27.3%
Revenue 1Y (TTM)10.4%
Revenue growth 3Y17.87%
Revenue growth 5Y30.16%
Sales Q2Q%6.69%
Revenue Next Year7.67%
Revenue Next 2Y8.71%
Revenue Next 3Y8.23%
Revenue Next 5Y5.69%
EBIT growth 1Y34.87%
EBIT growth 3Y57.41%
EBIT growth 5Y58.1%
EBIT Next Year8.84%
EBIT Next 3Y10.05%
EBIT Next 5Y6.96%
FCF growth 1Y10.41%
FCF growth 3Y35.46%
FCF growth 5Y40.4%
OCF growth 1Y17.36%
OCF growth 3Y37.76%
OCF growth 5Y42.16%

PROGYNY INC / PGNY Fundamental Analysis FAQ

What is the fundamental rating for PGNY stock?

ChartMill assigns a fundamental rating of 7 / 10 to PGNY.


What is the valuation status of PROGYNY INC (PGNY) stock?

ChartMill assigns a valuation rating of 6 / 10 to PROGYNY INC (PGNY). This can be considered as Fairly Valued.


Can you provide the profitability details for PROGYNY INC?

PROGYNY INC (PGNY) has a profitability rating of 7 / 10.


What are the PE and PB ratios of PROGYNY INC (PGNY) stock?

The Price/Earnings (PE) ratio for PROGYNY INC (PGNY) is 28.62 and the Price/Book (PB) ratio is 2.82.


Can you provide the financial health for PGNY stock?

The financial health rating of PROGYNY INC (PGNY) is 10 / 10.